Cidara Therapeutics, Inc. Business Finance Contracts & Agreements

Underwriting Agreement, dated March 3, 2023, by and between Cidara Therapeutics, Inc. and Cantor Fitzgerald & Co. (Series X Convertible Preferred Stock) (Filed With SEC on March 6, 2023)

Underwriting Agreement, dated March 3, 2023, by and between Cidara Therapeutics, Inc. and Cantor Fitzgerald & Co. (Common Stock) (Filed With SEC on March 6, 2023)

Fifth Amendment to Loan and Security Agreement by and between the Registrant and Pacific Western Bank, dated April 4, 2022 (Filed With SEC on August 9, 2022)

Underwriting Agreement, dated October 7, 2021, by and between Cidara Therapeutics, Inc. and Cantor Fitzgerald & Co. (Series X Convertible Preferred Stock) (Filed With SEC on October 8, 2021)

Underwriting Agreement, dated October 7, 2021, by and between Cidara Therapeutics, Inc. and Cantor Fitzgerald & Co. (Common Stock) (Filed With SEC on October 8, 2021)

Fourth Amendment to Loan and Security Agreement by and between the Registrant and Pacific Western Bank, dated March 16, 2021 (Filed With SEC on May 13, 2021)

Third Amendment to Loan and Security Agreement, by and between the Registrant and Pacific Western Bank, dated November 5, 2019 (Filed With SEC on February 25, 2021)

Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the Cidara (Filed With SEC on December 7, 2020)

Investment Agreement, dated January 9, 2020, by and among the Company and the signatories thereto (Filed With SEC on January 10, 2020)

Stock Purchase Agreement, dated September 3, 2019, by and between the Registrant and Mundipharma AG (Filed With SEC on November 8, 2019)

Exchange Agreement, dated March 22, 2019, between the Company and Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P., Biotechnology Value Trading Fund OS, L.P. and... (Filed With SEC on March 22, 2019)

First Amendment to Loan and Security Agreement, by and between the Registrant and Pacific Western Bank, dated June 13, 2018 (Filed With SEC on August 9, 2018)

Second Amendment to Loan and Security Agreement by and between Cidara Therapeutics, Inc. and Pacific Western Bank, dated July 27, 2018 (Filed With SEC on July 31, 2018)

Subscription Agreement (Filed With SEC on May 21, 2018)

Form of Common Stock Purchase Warrant for Second Private Placement (Filed With SEC on May 21, 2018)

Form of Common Stock Purchase Warrant for First Private Placement (Filed With SEC on May 21, 2018)

Securities Purchase Agreement, dated October 19, 2017, between the Company and the purchasers listed therein (Filed With SEC on October 20, 2017)

2,475,248 Shares Cidara Therapeutics, Inc. UNDERWRITING AGREEMENT (Filed With SEC on October 7, 2016)

WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on October 3, 2016)

CIDARA THERAPEUTICS, INC. LOAN AND SECURITY AGREEMENT (Filed With SEC on October 3, 2016)

CIDARA THERAPEUTICS, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS:MARCH 27, 2015 APPROVED BY THE STOCKHOLDERS:APRIL 1, 2015 (Filed With SEC on April 6, 2015)

[Number of Shares] Cidara Therapeutics, Inc. UNDERWRITING AGREEMENT (Filed With SEC on April 6, 2015)

ASSET PURCHASE AGREEMENT ACQUISITION OF CERTAIN ASSETS OF SEACHAID PHARMACEUTICALS, INC. BY K2 THERAPEUTICS,INC. DATED AS OF MAY 30, 2014 TABLE OF CONTENTS (Filed With SEC on March 13, 2015)

CIDARA THERAPEUTICS, INC. LOAN AND SECURITY AGREEMENT (Filed With SEC on March 13, 2015)

CIDARA THERAPEUTICS, INC. 2013 STOCK OPTION AND GRANT PLAN (Filed With SEC on March 13, 2015)

CIDARA THERAPEUTICS, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS: [], 2015 APPROVED BY THESTOCKHOLDERS: [], 2015 (Filed With SEC on March 13, 2015)

WARRANT TO PURCHASESTOCK (Filed With SEC on March 13, 2015)

CIDARA THERAPEUTICS, INC. SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT CIDARA THERAPEUTICS, INC. SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on March 13, 2015)